Autoimmune diseases and vitamin D receptor Apa-I polymorphism are associated with vitiligo in a small inbred Romanian community

Acta Dermato-Venereologica

Volumn 86, Issue 3, 2006, Pages 209-214

  Birlea, Stanca ^a   Birlea, Marius ^a   Cimponeriu, Danut ^b   Apostol, Pompilia ^b   Cosgarea, Rodica ^c   Gavrila, Lucian ^b   Tigan, Stefan ^c   Costin, Gertrude ^d   Das, Pranab ^e  

^a Zalau County Hospital   (Romania)

^b UNIVERSITY OF BUCHAREST   (Romania)

^c IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Associated diseases; Autoimmunity; Gene polymorphism; Vitamin D receptor; Vitiligo

Indexed keywords

VITAMIN D RECEPTOR;

ADULT; ALLELE; APA 1 GENE; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONSANGUINITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IMMUNE STATUS; MALE; PREVALENCE; PRIORITY JOURNAL; RECEPTOR GENE; RHEUMATOID ARTHRITIS; ROMANIA; VITILIGO;

EID: 33745019647     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0093     Document Type: Article

References (35)

1. Le Poole C, Das PK, van den Wijngaard RM, Bos JD, Westerhof W. Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol 1993; 2: 145-153.
2. Hann SK, Nordlund JJ. Definition of vitiligo. In: Hann SK, Nordlund JJ, eds. Vitiligo, 1st edn. Oxford: Blackwell Science, 2000; p. 3-6.
3. Ongenae K, Van Geel N, Naeyaert JM. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res 2003; 16: 90-100.
4. Cucchi ML, Frattini P, Santagostino G, Preda S, Orecchia G. Catecholamines increase in the urine of non-segmental vitiligo especially during its active phase. Pigment Cell Res 2003; 16: 111-116.
5. 2 stress. J Invest Dermatol 2004; 122: 307-313.
6. van den Wijngaard R, Wankowicz-Kalinska A, Le Poole C, Tigges B, Westerhof W, Das P. Local immune response in skin of generalized vitiligo patients: Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab Invest 2000; 80: 1299-1309.
7. Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003; 16: 208-214.
8. Kemp EH, Waterman EA, Weetman AP. Autoimmune aspects of vitiligo. Autoimmunity 2001; 34: 65-77.
9. Kemp EH, Waterman EA, Weetman PA. Immunological pathomechanisms in vitiligo. Expert Rev Mol Med 2001; 3: 1-22.
10. Nordlund JJ. The epidemiology and genetics of vitiligo. Clin Dermatol 1997; 15: 875-878.
11. Alkhateeb A, Stetler GL, Old W, Talbert J, Uhlhorn C, Taylor M, et al. Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. Hum Mol Genet 2002; 15: 661-667.
12. Rindfleisch JA, Muller D. Diagnosis and management of rheumatoid arthritis. Am Fam Physician 2005; 72: 1037-1047.
13. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
14. Pani MA, Knapp M, Donner H, Braun J, Baur MP, Usadel KH, et al. Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes 2000; 49: 504-507.
15. Das PK, van den Wijngaard RM, Wankowicz-Kalinska A, Le Poole IC. A symbiotic concept of autoimmunity and tumor immunity: lessons from vitiligo. Trends Immunol 2001; 22: 130-136.
16. Howitz J, Brodthagen H, Schwartz M, Thomsen K. Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark. Arch Dermatol 1977; 113: 47-52.
17. Ramaiah A, Mojamdar M, Amarnath VM. Vitiligo in the Ssk community of Bangalore (a preliminary report). Indian J Dermatol Venereol Leprol 1988; 54: 251-254.
18. Schallreuter KU, Lemke R, Brandt O, Schwartz R, Westhofen M, Montz R, et al. Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients. Dermatology 1994; 188: 269-275.
19. Laberge G, Mailloux CM, Gowan K, Holland P, Bennett DC, Fain PR, et al. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res 2005; 18: 300-305.
20. Taieb A. Intrinsic and extrinsic pathomechanism in vitiligo. Pigment Cell Res 2000; 13: 41-47.
21. Nordlund JJ, Majumder PP. Recent investigations on vitiligo vulgaris. Dermatol Clin 1997; 15: 69-78.
22. Le Poole C, Wankowicz-Kalinska A, van den Wijngaard RM, Nickoloff BJ, Das PK. Autoimmune aspects of depigmentation in vitiligo. J Invest Dermatol Symp Proc 2004; 9: 68-72.
23. Nath SK, Kelly JA, Namjou B, Lam T, Bruner GR, Scofield RH, et al. Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus. Am J Hum Genet 2001; 69: 1401-1406.
24. Spritz RA, Gowan K, Bennett DC, Fain PR. Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am J Hum Genet 2004; 74: 188-191.
25. Casp CB, She J-X, McCormack WT. Genetic association of the catalase gene (CAT) with vitiligo susceptibility. Pigment Cell Res 2002; 15: 62-66.
26. Gauthier Y, Cario Andre M, Taieb A. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res 2003; 16: 322-332.
27. Kroll TM, Bommiasamy H, Boissy RE, Hernandez C, Nickoloff BJ, Mestril R, Caroline Le Poole I. 4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo. J Invest Dermatol 2005; 124: 798-806.
28. Ban Y, Taniyama M, Ban Y. Vitamin D receptor gene polymorphisms in Hashimoto's thyroiditis. Thyroid 2001; 11: 607-608.
29. Ban Y, Taniyama M, Yanagawa T, Yamada S, Maruyama T, Kasuga A, et al. Vitamin D receptor initiation codon polymorphism influences genetic susceptibility to type 1 diabetes mellitus in the Japanese population. BMC Med Genet 2001; 2: 7.
30. Garcia-Lozano JR, Gonzalez-Escribano MF, Valenzuela A, Garcia A, Nunez-Roldan A. Association of vitamin D receptor genotypes with early onset rheumatoid arthritis. Eur J Immunogenet 2001; 28: 89-93.
31. Wright AF, Carothers AD, Pirastu M. Population choice in mapping genes for complex diseases. Nat Genet 1999; 23: 397-404.
32. Fukai K, Frenk E, Almodovar C, Spritz RA. Linkage disequilibrium mapping of the gene for Hermansky-Pudlak syndrome to chromosome 10q32.1-q23.3. Hum Mol Genet 1995; 4: 1665-1669
33. Oh J, Bailin T, Fukai K, Feng GH, Ho L, Mao JI, et al. Positional cloning of a gene for Hermansky-Pudlak syndrome, a disorder of cytoplasmic organelles. Nat Genet 1996; 14: 300-306.
34. Suzuki K, Hu D, Bustos T, Zlotogora J, Richieri-Costa A, Helms JA, et al. Mutations of PVRL1, encoding a cell-cell adhesion molecule/herpesvirus receptor, in cleft lip/palate-ectodermal dysplasia. Nat Genet 2000; 25: 427-430
35. Te Meerman GJ, Van der Meulen MA, Sandkuijl LA. Perspectives of identity by descent (IBD) mapping in founder population. Clin Exp Allergy 1995; 25: 97-102.